NASDAQ:PROK
ProKidney Corp. Stock News
$3.03
-0.450 (-12.93%)
At Close: Jun 03, 2024
ProKidney Corp. (PROK) Loses -54.93% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
11:19am, Tuesday, 17'th Oct 2023
ProKidney Corp. (PROK) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings est
Is Chamath Palihapitiya Giving Up on ProKidney (PROK) Stock?
02:50pm, Monday, 16'th Oct 2023
Shares of ProKidney (NASDAQ: PROK ) are in the green today, despite recent sales from special purpose acquisition company (SPAC) sponsor Chamath Palihapitiya. Back in July of 2022, ProKidney agreed to
Why Shares of ProKidney Were Dropping Thursday
03:05pm, Thursday, 12'th Oct 2023
ProKidney focuses on therapies to treat chronic kidney disease (CKD). One of its top shareholders sold roughly $1.23 million worth of company stock.
Short squeeze alert for September 27th: 2 stocks that could skyrocket
09:38am, Wednesday, 27'th Sep 2023
Stock market investors are regularly monitoring highly shorted stocks, as the potential for an abrupt surge looms large.
ProKidney to Participate in Fireside Chat at the Morgan Stanley Global Healthcare Conference
06:05am, Tuesday, 05'th Sep 2023
WINSTON-SALEM, N.C., Sept. 05, 2023 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company”), a leading late clinical-stage cellular therapeutics company focused on pr
Short squeeze alert for September 4th: Two stocks with potential to skyrocket
08:24am, Monday, 04'th Sep 2023
A short squeeze is when traders who heavily short a stock start to cover their short positions by buying back the stock. This increases demand for the stock, and it pushes the price higher, forcing ot
3 Biotech Stocks Due for a Massive Short Squeeze
10:33am, Thursday, 31'st Aug 2023
Here's a look at 3 biotech short squeeze candidates. For investors looking for short-term gains, technical analysis provides key insights on potential entry and exit points.
ProKidney to Present at the BofA Securities Health Care Conference 2023
06:05am, Thursday, 04'th May 2023
WINSTON-SALEM, N.C., May 04, 2023 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney”), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (C
ProKidney: Too Many Billionaires, Too Little Data
11:51am, Wednesday, 12'th Apr 2023
ProKidney Corp. has a noble goal - ending kidney dysfunction using cell therapy. It has produced some interesting data from a phase 2 trial.
ProKidney's stock jumps 29%
07:48am, Wednesday, 11'th Jan 2023
Shares of ProKidney Corp. PROK, +9.57% rallied about 29% in premarket trading on Wednesday, the day after the company said preliminary data from a Phase 2 study found that the company's investigationa
ProKidney to Present at the J.P. Morgan 41st Annual Healthcare Conference
06:05am, Thursday, 22'nd Dec 2022
WINSTON-SALEM, N.C., Dec. 22, 2022 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney”), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (
ProKidney to Participate in Upcoming Investor Conferences
04:05pm, Friday, 11'th Nov 2022
WINSTON-SALEM, N.C., Nov. 11, 2022 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney”), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (
ProKidney to Present at the Jefferies Cell and Genetic Medicine Summit
06:15am, Friday, 23'rd Sep 2022
WINSTON-SALEM, N.C., Sept. 23, 2022 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney”), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease
ProKidney to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
06:05am, Thursday, 08'th Sep 2022
WINSTON-SALEM, N.C., Sept. 08, 2022 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney”), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease
ProKidney to present at upcoming investor conferences
09:00am, Friday, 20'th May 2022
WINSTON-SALEM, N.C., May 20, 2022 (GLOBE NEWSWIRE) -- ProKidney LP (ProKidney), a leading clinical-stage cellular therapeutics company focused on the treatment of chronic kidney disease (CKD) and the
